LXRX Price / Book | LEXICON PHARMACEUTICALS, INC.

LEXICON PHARMACEUTICALS, INC. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

LEXICON PHARMACEUTICALS, INC. price/book ratio for the quarter ending 2026-06-30 was 6.12, a 129.56% increase year-over-year.
LEXICON PHARMACEUTICALS, INC. price/book ratio for the quarter ending 2026-03-31 was 3.27, a 142.22% increase year-over-year.
LEXICON PHARMACEUTICALS, INC. price/book ratio for the quarter ending 2025-12-31 was 3.88, a 110.71% increase year-over-year.
LEXICON PHARMACEUTICALS, INC. price/book ratio for the quarter ending 2025-09-30 was 4.11, a 29.26% increase year-over-year.
LEXICON PHARMACEUTICALS, INC. price/book ratio for fiscal 2026 was 6.12.
LEXICON PHARMACEUTICALS, INC. price/book ratio for fiscal 2025 was 3.88, a 110.71% increase from fiscal 2024.
LEXICON PHARMACEUTICALS, INC. price/book ratio for fiscal 2024 was 1.84, a 54.27% decline from fiscal 2023.
LEXICON PHARMACEUTICALS, INC. price/book ratio for fiscal 2023 was 4.02, a 30.19% increase from fiscal 2022.

Available history: 2011-09-30 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	6.12	$1.07B	$174.53M
2026-03-31	3.27	$664.11M	$202.86M
2025-12-31	3.88	$417.07M	$107.54M
2025-09-30	4.11	$493.8M	$120.16M
2025-06-30	2.67	$345.06M	$129.44M
2025-03-31	1.35	$166.29M	$123.03M
2024-12-31	1.84	$268.64M	$145.95M
2024-09-30	3.18	$567.54M	$178.51M
2024-06-30	1.72	$413.68M	$239.98M
2024-03-31	2.05	$590.97M	$288.87M
2023-12-31	4.02	$374.73M	$93.11M
2023-09-30	1.91	$266.97M	$139.51M
2023-06-30	2.32	$432.18M	$186.36M
2023-03-31	5.21	$458.6M	$88.05M
2022-12-31	3.09	$362.06M	$117.12M
2022-09-30	3.06	$440.7M	$144.02M
2022-06-30	3.93	$278.24M	$70.83M
2022-03-31	3.36	$311.19M	$92.7M
2021-12-31	5.16	$586.65M	$113.6M
2021-09-30	5.09	$694.92M	$136.6M
2021-06-30	4.83	$662.74M	$137.23M
2020-12-31	2.57	$401.76M	$156.37M
2020-09-30	1.76	$154.23M	$87.64M
2020-06-30	-20.02	$213.94M	-$10.69M
2020-03-31	5.14	$281.49M	$54.78M
2019-12-31	3.77	$441.03M	$117.1M
2019-09-30	1.94	$319.88M	$164.71M
2019-06-30	-10.3	$668.45M	-$64.89M
2019-03-31	-12.93	$590.87M	-$45.69M
2018-12-31	-26.64	$703.34M	-$26.41M
2018-09-30	-88.88	$1.13B	-$12.71M
2018-06-30	110.39	$1.27B	$11.5M
2018-03-31	21.24	$904.92M	$42.61M
2017-12-31	15.28	$1.04B	$68.27M
2017-09-30	16.56	$1.3B	$78.38M
2017-06-30	16.28	$1.73B	$106.31M
2017-03-31	11.11	$1.5B	$134.6M
2016-12-31	9.14	$1.44B	$157.4M
2016-09-30	10.14	$1.88B	$185.18M
2016-06-30	6.86	$1.49B	$217.33M
2016-03-31	4.9	$1.24B	$252.88M
2015-12-31	4.82	$1.38B	$285.85M
2015-09-30	5.62	$1.11B	$197.94M
2015-06-30	25.22	$5.84B	$231.47M
2015-03-31	18.52	$4.77B	$257.61M
2014-12-31	11.55	$3.28B	$284.02M
2014-09-30	65.29	$5.08B	$77.82M
2014-06-30	49.74	$5.8B	$116.67M
2014-03-31	44.2	$6.22B	$140.78M
2013-12-31	38.02	$6.47B	$170.16M
2013-09-30	46.06	$8.55B	$185.71M
2013-06-30	36.23	$7.79B	$215.08M
2013-03-31	32.32	$7.83B	$242.21M
2012-12-31	29.72	$7.93B	$266.68M
2012-09-30	31.76	$8.03B	$252.76M
2012-06-30	30.91	$7.57B	$244.9M
2012-03-31	23.26	$6.26B	$268.97M
2011-12-31	10.25	$3.05B	$297.57M
2011-09-30	12.83	$2.17B	$169.48M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	6.12	$1.07B	$174.53M
2025-12-31	3.88	$417.07M	$107.54M
2024-12-31	1.84	$268.64M	$145.95M
2023-12-31	4.02	$374.73M	$93.11M
2022-12-31	3.09	$362.06M	$117.12M
2021-12-31	5.16	$586.65M	$113.6M
2020-12-31	2.57	$401.76M	$156.37M
2019-12-31	3.77	$441.03M	$117.1M
2018-12-31	-26.64	$703.34M	-$26.41M
2017-12-31	15.28	$1.04B	$68.27M
2016-12-31	9.14	$1.44B	$157.4M
2015-12-31	4.82	$1.38B	$285.85M
2014-12-31	11.55	$3.28B	$284.02M
2013-12-31	38.02	$6.47B	$170.16M
2012-12-31	29.72	$7.93B	$266.68M
2011-12-31	10.25	$3.05B	$297.57M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
GYRE THERAPEUTICS, INC. (GYRE)	United States	$0.818B	-24.71
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
GERON CORP (GERN)	United States	$0.803B	-12.14
Aclaris Therapeutics, Inc. (ACRS)	United States	$0.792B	-9.78
Olema Pharmaceuticals, Inc. (OLMA)	United States	$0.790B	-5.35
ARDELYX, INC. (ARDX)	United States	$0.857B	-22.86
Wave Life Sciences, Inc. (WVE)		$0.780B	-5.56
Design Therapeutics, Inc. (DSGN)	United States	$0.766B	-12.78